ISI Web of Knowledge Take the next step  
Web of Science®
 
Previous Record (inactive) Record 1  of  1 Next Record (inactive)
Record from Web of Science®
Lipoprotein-associated phospholipase A(2) as an independent predictor of coronary heart disease.
Author(s): Packard CJ, O'Reilly DSJ, Caslake MJ, McMahon AD, Ford I, Cooney J, Macphee CH, Suckling KE, Krishna M, Wilkinson FE, Rumley A, Lowe GDO
Source: NEW ENGLAND JOURNAL OF MEDICINE    Volume: 343    Issue: 16    Pages: 1148-1155    Published: OCT 19 2000  
Times Cited: 372     References: 32     
Abstract: Background: Chronic inflammation is believed to increase the risk of coronary events by making atherosclerotic plaques in coronary vessels prone to rupture. We examined blood constituents potentially affected by inflammation as predictors of risk in men with hypercholesterolemia who were enrolled in the West of Scotland Coronary Prevention Study, a trial that evaluated the value of pravastatin in the prevention of coronary events.

Methods: A total of 580 men who had had a coronary event (nonfatal myocardial infarction, death from coronary heart disease, or a revascularization procedure) were each matched for age and smoking status with 2 control subjects (total, 1160) from the same cohort who had not had a coronary event. Lipoprotein-associated phospholipase A(2), C-reactive protein, and fibrinogen levels and the white-cell count were measured at base line, along with other traditional risk factors. The association of these variables with the risk of coronary events was tested in regression models and by dividing the range of values according to quintiles.

Results: Levels of C-reactive protein, the white-cell count, and fibrinogen levels were strong predictors of the risk of coronary events; the risk in the highest quintile of the study cohort for each variable was approximately twice that in the lowest quintile. However, the association of these variables with risk was markedly attenuated when age, systolic blood pressure, and lipoprotein levels were included in multivariate models. Levels of lipoprotein-associated phospholipase A(2) (platelet-activating factor acetylhydrolase), the expression of which is regulated by mediators of inflammation, had a strong, positive association with risk that was not confounded by other factors. It was associated with almost a doubling of the risk in the highest quintile as compared with the lowest quintile.

Conclusions: Inflammatory markers are predictors of the risk of coronary events, but their predictive ability is attenuated by associations with other coronary risk factors. Elevated levels of lipoprotein-associated phospholipase A(2) appear to be a strong risk factor for coronary heart disease, a finding that has implications for atherogenesis and the assessment of risk. (N Engl J Med 2000;343:1148-55.) (C) 2000 Massachusetts Medical Society.

Document Type: Article
Language: English
Reprint Address: Packard, CJ (reprint author), Glasgow Royal Infirm Univ NHS Trust, Glasgow Royal Infirm, Dept Pathol Biochem, 4th Fl Queen Elizabeth Bldg,10 Alexandra Parade, Glasgow G31 2ER, Lanark Scotland
Addresses:
1. Glasgow Royal Infirm Univ NHS Trust, Glasgow Royal Infirm, Dept Pathol Biochem, Glasgow G31 2ER, Lanark Scotland
2. Glasgow Royal Infirm, Dept Med, Glasgow G31 2ER, Lanark Scotland
3. Univ Glasgow, Robertson Ctr Biostat, Glasgow, Lanark Scotland
4. SmithKline Beecham Pharmaceut, Harlow CM19 5AD, Essex England
5. diaDexus, Santa Clara, CA USA
Publisher: MASSACHUSETTS MEDICAL SOC, WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA
Subject Category: Medicine, General & Internal
IDS Number: 364FY
ISSN: 0028-4793
Previous Record (inactive) Record 1  of  1 Next Record (inactive)
Record from Web of Science®
  
Thomson Reuters Logo